Novel test measures protection against HIV
This article was originally published in Clinica
US researchers have developed an in vitro assay that tests a person's protection against HIV-1 infection and could provide a useful method for determining the effectiveness of HIV vaccines.
You may also be interested in...
Teva received a “package of commercial side-deals” for agreeing to halt generic competition to Cephalon’s Provigil (modafinil) throughout the EU, which it “would not have achieved without committing to staying out of the market,” according to findings by the European Commission.
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma